Taysha Gene Therapies, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC TSHA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

167,500

Value ($000)

921

Weight

0.0%

2020 Q3 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	921	0.0%	167,500	12/31/2025
2020 Q3	11/13/2020	4,480	0.0%	200,000	9/30/2020